HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS		QUICK SEARCH:   [advanced] Author: Keyword(s): Year:  Vol:  Page:

This Article Full Text Full Text (PDF) All Versions of this Article: M400362-JLR200v1 46/3/494    most recent Alert me when this article is cited Alert me if a correction is posted Citation Map Services Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Snyder, P. B. Articles by Florio, V. A. Search for Related Content PubMed PubMed Citation Articles by Snyder, P. B. Articles by Florio, V. A. Social Bookmarking                      What's this?

Journal of Lipid Research, Vol. 46, 494-503, March 2005
Copyright © 2005 by American Society for Biochemistry and Molecular Biology

The role of cyclic nucleotide phosphodiesterases in the regulation of adipocyte lipolysis

Peter B. Snyder¹, James M. Esselstyn, Kate Loughney, Sharon L. Wolda and Vincent A. Florio

ICOS Corporation, Bothell, WA 98021

¹ To whom correspondence should be addressed. e-mail: psnyder{at}icos.com

This study assessed the effects of selective inhibitors of 3',5'-cyclic nucleotide phosphodiesterases (PDEs) on adipocyte lipolysis. IC224, a selective inhibitor of type 1 phosphodiesterase (PDE1), suppressed lipolysis in murine 3T3-L1 adipocytes (69.6 ± 5.4% of vehicle control) but had no effect in human adipocytes. IC933, a selective inhibitor of PDE2, had no effect on lipolysis in either cultured murine 3T3-L1 adipocytes or human adipocytes. Inhibition of PDE3 with cilostamide moderately stimulated lipolysis in murine 3T3-L1 and rat adipocytes (397 ± 25% and 235 ± 26% of control, respectively) and markedly stimulated lipolysis in human adipocytes (932 ± 7.6% of control). Inhibition of PDE4 with rolipram moderately stimulated lipolysis in murine 3T3-L1 adipocytes (291 ± 13% of control) and weakly stimulated lipolysis in rat adipocytes (149 ± 7.0% of control) but had no effect on lipolysis in human adipocytes. Cultured adipocytes also responded differently to a combination of PDE3 and PDE4 inhibitors. Simultaneous exposure to cilostamide and rolipram had a synergistic effect on lipolysis in murine 3T3-L1 and rat adipocytes but not in human adipocytes.

Hence, the relative importance of PDE3 and PDE4 in regulating lipolysis differed in cultured murine, rat, and human adipocytes.

Abbreviations: AC, adenylyl cyclase; BMI, body mass index; DPCPX, 8-cyclopentyl-1,3-dipropylxanthine; G_s, stimulatory guanine nucleotide binding protein; HSL, hormone-sensitive lipase; IBMX, 3-isobutyl-1-methylxanthine; ISO, isoproterenol; PDE, 3',5'-cyclic nucleotide phosphodiesterase; PDEx, type x phosphodiesterase; PKA, cAMP-dependent protein kinase; RIIß, cAMP-dependent protein kinase regulatory subunit IIß; R_max, maximal response; TG, triglyceride

Supplementary key words cilostamide • rolipram • triglyceride

CiteULike    Complore    Connotea    Del.icio.us    Digg    Reddit    Technorati    What's this?

This article has been cited by other articles:

				H. Wang and N. K. Edens mRNA expression and antilipolytic role of phosphodiesterase 4 in rat adipocytes in vitro J. Lipid Res., May 1, 2007; 48(5): 1099 - 1107. [Abstract] [Full Text] [PDF]

				M. R. Peluso Flavonoids Attenuate Cardiovascular Disease, Inhibit Phosphodiesterase, and Modulate Lipid Homeostasis in Adipose Tissue and Liver Experimental Biology and Medicine, September 1, 2006; 231(8): 1287 - 1299. [Abstract] [Full Text] [PDF]

				A. T. Bender and J. A. Beavo Cyclic Nucleotide Phosphodiesterases: Molecular Regulation to Clinical Use Pharmacol. Rev., September 1, 2006; 58(3): 488 - 520. [Abstract] [Full Text] [PDF]

				L. Kang and L. E. Nagy Chronic Ethanol Feeding Suppresses {beta}-Adrenergic Receptor-Stimulated Lipolysis in Adipocytes Isolated from Epididymal Fat Endocrinology, September 1, 2006; 147(9): 4330 - 4338. [Abstract] [Full Text] [PDF]